DRL launches Renvela generic in US, price target at Rs 2200: HDFC Securities News News / News 6 years ago 446 Views comments The pharma major Dr Reddys Laboratories (DRL) has launched kidney disease drug Renvela generic in the US market. How big an opportunity can this be fo... Read more
News Can individuals sue government, companies for personal data misuse: Panel News / News - 6 years ago
News Gujarat High Court verdict on appeals in Godhra train burning case likely today News / News - 6 years ago
News Babri Masjid: Amicable solution by mutual discussion can be looked at, says Mulayam Singh News / News - 6 years ago
Comments